Showing results (1141-1150 of 1,350) with videos related to

Sort By:
Pageof 135
Drug Development Research|June 16, 2022
Papaverine, a promising therapeutic agent for the treatment of COVID-19 patients with underlying cardiovascular diseases (CVDs)Mehdi Valipour, Hamid Irannejad, Saeed Emami
Drug Development Research|July 5, 2022
Therapeutic potential of targeting the receptor for advanced glycation end products (RAGE) by small molecule inhibitorsHarbinder Singh, Devendra K Agrawal
Drug Development Research|January 8, 2021
Biomarkers to predict staging and treatment response in opioid dependence: A narrative reviewFlorence Vorspan, Cynthia Marie-Claire, Frank Bellivier, et al.
Drug Development Research|January 8, 2021
Design, synthesis, and structure-activity relationship study of O-prenylated 3-acetylcoumarins as potent inhibitors of soybean 15-lipoxygenaseSara Zerangnasrabad, Atena Jabbari, Elahe Khavari Moghadam, et al.
Drug Development Research|June 2, 2021
A quinazoline-based bromodomain inhibitor, CN210, ameliorates indomethacin-induced ileitis in mice by inhibiting inflammatory cytokine expressionTakehisa Noguchi, Kyosuke Hidaka, Satsuki Kobayashi, et al.
Drug Development Research|November 15, 2020
CB2 receptor-selective agonists as candidates for targeting infection, inflammation, and immunity in SARS-CoV-2 infectionsM F Nagoor Meeran, Charu Sharma, Sameer N Goyal, et al.
Drug Development Research|May 31, 2021
CircMYLK promotes the growth, migration, invasion, and survival of bladder cancer cells by upregulating CCND3 level via competitively binding to miR-34aWenxin Ye, Li Chen, Chao Feng, et al.
Drug Development Research|February 13, 2020
Targeting neutrophils using novel drug delivery systems in chronic respiratory diseasesDinesh K Chellappan, Lim W Yee, Kong Y Xuan, et al.
Drug Development Research|February 18, 2020
Paeoniflorin alleviates lipopolysaccharide-induced disseminated intravascular coagulation by inhibiting inflammation and coagulation activationYushan Fang, Liang-Cai Wu, Kanglong Ma, et al.
Drug Development Research|March 5, 2020
Effect of age and renal impairment on the pharmacokinetics and safety of trimetazidine: An open-label multiple-dose studyNencho Nenchev, Jiri Skopek, Deepa Arora, et al.
Pageof 135